April 30, 2025 - 15:00 BST / 16:00 CEST / 10:00 EDT / 07:00 PDT

The Coalition for Global Hepatitis Elimination (CGHE) is dedicated to accelerating the eradication of hepatitis B and C worldwide. Operating under the Task Force for Global Health, CGHE collaborates with various partners to enhance the capacity of national and sub-national elimination programs. During this webinar, attendees will learn about CGHE objectives, plan, and updated status and examine current challenges in testing, including accessibility and accuracy.

Key learning objectives

  • Identify key challenges and barriers in global hepatitis elimination efforts and explore strategies to overcome them
  • Discuss the Coalition for Global Hepatitis Elimination (CGHE)—its mission, programs, and impact on advancing elimination goals
  • Explain how improvements in laboratory workflow efficiencies in diagnostics play an essential role in initiatives such as Hepatitis elimination

Who should attend

Healthcare professionals, clinical staff, lab technicians, pathologists, lab directors, laboratorians, researchers and academics

Accreditation statement

SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of these webinars may be entitled to 1.0 ACCENT Continuing Education Credits from the ADLM. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@myadlm.org

Presenters

Alan H.B. Wu, PhD

Alan H.B. Wu, PhD

Chief of Clinical Chemistry and Toxicology, Professor of Laboratory Medicine

San Francisco General Hospital, University of California, San Francisco

Alan H.B. Wu, Ph.D., is Chief of Clinical Chemistry and Toxicology at San Francisco General Hospital and Professor of Lab Medicine, University of California, San Francisco. He received B.S. degrees in chemistry and biology at Purdue University and a Ph.D. degree in analytical chemistry at the University of Illinois. He completed a postdoctoral fellowship in clinical chemistry at Hartford Hospital. He is certified by the American Board of Clinical Chemistry in Clinical Chemistry and Toxicological Chemistry. His research interests include clinical toxicology, cardiac biomarkers, and point-of-care testing. Dr. Wu has over 500 publications in peer-reviewed journals.

 

Dr. John W. Ward

Dr. John W. Ward

Director, Coalition for Global Hepatitis Elimination,

Task Force for Global Health

Over a 40-year career, Dr. Ward’s work spans the practice of epidemiology, laboratory science, clinical trials, public health program practice, policy development, health communication, education, and clinical medicine in the prevention and control of HIV/AIDS and the elimination of viral hepatitis. He currently directs the Coalition for Global Hepatitis Elimination of the Task Force for Global Health providing a community of practice for hepatitis elimination programs to collaborate, receive technical assistance, and participate in operational research.
Sarah Thomas

Sarah Thomas

Associate Editor

SelectScience

Register

Note: By completing this form, you will receive a free membership to SelectScience® and The Scientists’ Channel®. SelectScience is a trade organisation, we do not provide services to consumers and membership is for business purposes only. As a member you must provide us with a corporate email address to enable us (and our advertisers and sponsors) to contact you for marketing purposes. You can opt-out of marketing at any time. See our Privacy Policy

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

* Required Fields